Hyperion Asset Management Ltd Sells 7,447 Shares of Axon Enterprise, Inc $AXON

Hyperion Asset Management Ltd lowered its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 3.4% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 213,509 shares of the biotechnology company’s stock after selling 7,447 shares during the quarter. Axon Enterprise accounts for approximately 3.2% of Hyperion Asset Management Ltd’s portfolio, making the stock its 14th largest position. Hyperion Asset Management Ltd’s holdings in Axon Enterprise were worth $119,695,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Darwin Wealth Management LLC acquired a new position in shares of Axon Enterprise during the second quarter worth approximately $37,000. Creative Financial Designs Inc. ADV acquired a new position in Axon Enterprise during the fourth quarter worth $28,000. Sound Income Strategies LLC grew its holdings in shares of Axon Enterprise by 550.0% during the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after buying an additional 44 shares during the last quarter. Camelot Portfolios LLC acquired a new position in shares of Axon Enterprise during the fourth quarter valued at about $30,000. Finally, AlphaCentric Advisors LLC bought a new stake in shares of Axon Enterprise during the fourth quarter worth about $34,000. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Stock Up 6.7%

AXON stock opened at $636.31 on Wednesday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15. The company has a market capitalization of $51.69 billion, a price-to-earnings ratio of 264.03, a PEG ratio of 12.17 and a beta of 1.39. Axon Enterprise, Inc has a fifty-two week low of $339.01 and a fifty-two week high of $824.66. The stock has a fifty day moving average of $519.11 and a 200-day moving average of $473.46.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.84 by $0.04. The business had revenue of $904.39 million for the quarter, compared to analysts’ expectations of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The firm’s quarterly revenue was up 35.3% compared to the same quarter last year. During the same period in the previous year, the business posted $2.12 EPS. As a group, equities research analysts predict that Axon Enterprise, Inc will post 1.63 earnings per share for the current year.

Wall Street Analyst Weigh In

AXON has been the subject of a number of analyst reports. Piper Sandler lifted their price target on Axon Enterprise from $724.00 to $732.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. Morgan Stanley lifted their target price on Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. Needham & Company LLC reissued a “buy” rating on shares of Axon Enterprise in a research report on Thursday, August 6th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, July 21st. Finally, Citizens Jmp reiterated a “market outperform” rating and issued a $700.00 target price on shares of Axon Enterprise in a research note on Thursday, June 25th. Thirteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, Axon Enterprise presently has an average rating of “Moderate Buy” and an average target price of $730.92.

Insider Activity at Axon Enterprise

In related news, insider Elizabeth Reid Coughlin sold 1,554 shares of the firm’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $485.00, for a total value of $753,690.00. Following the completion of the transaction, the insider directly owned 34,024 shares of the company’s stock, valued at approximately $16,501,640. This trade represents a 4.37% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, President Joshua Isner sold 13,000 shares of Axon Enterprise stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $488.45, for a total transaction of $6,349,850.00. Following the completion of the transaction, the president owned 169,125 shares of the company’s stock, valued at $82,609,106.25. This represents a 7.14% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 68,989 shares of company stock worth $36,016,932 in the last ninety days. Insiders own 4.20% of the company’s stock.

Axon Enterprise News Roundup

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Earnings beat supports the rally: Axon reported quarterly earnings of $1.88 per share versus the $1.84 consensus estimate, while revenue of $904.4 million exceeded expectations of $876.4 million. Revenue increased 35.3% year over year, reinforcing the company’s strong demand across connected public-safety hardware and software. Axon Jumps After Earnings Beat and Analyst Target Hikes
• Positive Sentiment: Analyst support and future catalysts: Analyst target increases and the post-earnings rebound have improved sentiment, with investors awaiting the next potential growth catalyst. The company’s expanding product ecosystem and strong top-line growth remain central to the bullish case. Analyst Target Hikes and Next Catalyst
• Neutral Sentiment: Short-interest data provides no signal: Reported short interest was zero shares, with a zero-day days-to-cover ratio. Because the figures show no meaningful short position, they are unlikely to explain the stock’s move or provide useful evidence of future buying pressure.
• Negative Sentiment: Valuation remains demanding: Commentary highlights Axon’s strong growth but also its high valuation, while another analyst downgraded the stock and suggested taking some profits. The shares trade at a very high earnings multiple, leaving them vulnerable if growth or profitability disappoints. Axon Rating Downgrade
• Negative Sentiment: Margin pressure and insider selling temper enthusiasm: Investors remain focused on memory costs and counter-drone hardware expenses, which may constrain margins as Axon invests for growth. CEO Patrick W. Smith also sold approximately $5.5 million of shares under a pre-arranged Rule 10b5-1 plan, though the sale represented only about 0.33% of his holdings.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.